Literature DB >> 21357290

Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa.

Kristen N Kindrachuk1, Lucía Fernández, Manjeet Bains, Robert E W Hancock.   

Abstract

The adaptive resistance of Pseudomonas aeruginosa to aminoglycosides is known to occur during chronic lung infections in cystic fibrosis patients in response to nonlethal concentrations of aminoglycosides. Not only is it difficult to achieve high levels of drug throughout the dehydrated mucus in the lung, but also steep oxygen gradients exist across the mucus layer, further reducing the bactericidal activity of aminoglycosides. In this study, microarray analysis was utilized to examine the gene responses of P. aeruginosa to lethal, inhibitory, and subinhibitory concentrations of tobramycin under aerobic and anaerobic conditions. While prolonged exposure to subinhibitory concentrations of tobramycin caused increased levels of expression predominantly of the efflux pump genes mexXY, the greatest increases in gene expression levels in response to lethal concentrations of tobramycin involved a number of heat shock genes and the PA0779 gene (renamed here asrA), encoding an alternate Lon protease. Microarray analysis of an asrA::luxCDABE transposon mutant revealed that the induction of heat shock genes in response to tobramycin in this mutant was significantly decreased compared to that in the parent strain. The level of expression of asrA was induced from an arabinose-inducible promoter to 35-fold greater than wild-type expression levels in the absence of tobramycin, and this overexpression alone caused an increased expression of the heat shock genes, as determined by quantitative PCR (qPCR). This overexpression of asrA conferred short-term protection against lethal levels (4 μg/ml) of tobramycin but did not affect the tobramycin MIC. The RpoH heat shock sigma factor was found to be involved in the regulation of asrA in response to both heat shock and tobramycin at the posttranscriptional level. The results of this work suggest that the tobramycin concentration has a significant impact on the gene expression of P. aeruginosa, with lethal concentrations resulting in immediate adaptations conferring short-term protection, such as the induction of the heat shock response, and with subinhibitory concentrations leading to more sustainable long-term protection mechanisms, such as increased efflux.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357290      PMCID: PMC3088180          DOI: 10.1128/AAC.00935-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

1.  Comprehensive transposon mutant library of Pseudomonas aeruginosa.

Authors:  Michael A Jacobs; Ashley Alwood; Iyarit Thaipisuttikul; David Spencer; Eric Haugen; Stephen Ernst; Oliver Will; Rajinder Kaul; Christopher Raymond; Ruth Levy; Liu Chun-Rong; Donald Guenthner; Donald Bovee; Maynard V Olson; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

2.  Hydrogen cyanide, a secondary metabolite of Pseudomonas aeruginosa.

Authors:  P A Castric
Journal:  Can J Microbiol       Date:  1975-05       Impact factor: 2.419

3.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Dual control of hydrogen cyanide biosynthesis by the global activator GacA in Pseudomonas aeruginosa PAO1.

Authors:  G Pessi; D Haas
Journal:  FEMS Microbiol Lett       Date:  2001-06-12       Impact factor: 2.742

5.  Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.

Authors:  D L MacLeod; L E Nelson; R M Shawar; B B Lin; L G Lockwood; J E Dirk; G H Miller; J L Burns; R L Garber
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

6.  Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.

Authors:  Mara L Sobel; Geoffrey A McKay; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins.

Authors:  R T Irvin; J W Govan; J A Fyfe; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

8.  Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport.

Authors:  L E Bryan; S Kwan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

9.  The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa.

Authors:  Alexander J Carterson; Lisa A Morici; Debra W Jackson; Anders Frisk; Stephen E Lizewski; Ryan Jupiter; Kendra Simpson; Daniel A Kunz; Scott H Davis; Jill R Schurr; Daniel J Hassett; Michael J Schurr
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

10.  MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Didier Hocquet; Christelle Vogne; Farid El Garch; Anne Vejux; Naomasa Gotoh; Angela Lee; Olga Lomovskaya; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  28 in total

1.  Role of intracellular proteases in the antibiotic resistance, motility, and biofilm formation of Pseudomonas aeruginosa.

Authors:  Lucía Fernández; Elena B M Breidenstein; Diana Song; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms.

Authors:  Philip S Stewart; Michael J Franklin; Kerry S Williamson; James P Folsom; Laura Boegli; Garth A James
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

3.  Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.

Authors:  Katherine E Price; Amanda A Naimie; Edward F Griffin; Charles Bay; George A O'Toole
Journal:  J Bacteriol       Date:  2015-10-19       Impact factor: 3.490

Review 4.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

6.  Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1.

Authors:  Elena B M Breidenstein; Manjeet Bains; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

7.  Dynamic Proteome Response of Pseudomonas aeruginosa to Tobramycin Antibiotic Treatment.

Authors:  Xia Wu; Kiara Held; Chunxiang Zheng; Benjamin J Staudinger; Juan D Chavez; Chad R Weisbrod; Jimmy K Eng; Pradeep K Singh; Colin Manoil; James E Bruce
Journal:  Mol Cell Proteomics       Date:  2015-05-27       Impact factor: 5.911

8.  Chaperonins fight aminoglycoside-induced protein misfolding and promote short-term tolerance in Escherichia coli.

Authors:  Lise Goltermann; Liam Good; Thomas Bentin
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

9.  The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin.

Authors:  Boo Shan Tseng; Wei Zhang; Joe J Harrison; Tam P Quach; Jisun Lee Song; Jon Penterman; Pradeep K Singh; David L Chopp; Aaron I Packman; Matthew R Parsek
Journal:  Environ Microbiol       Date:  2013-06-10       Impact factor: 5.491

Review 10.  Antibiotic-Resistant Bacteria in Aquaculture and Climate Change: A Challenge for Health in the Mediterranean Area.

Authors:  Milva Pepi; Silvano Focardi
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.